US Map / New Mexico
State NM

Clinical Trials in New Mexico

Recruiting clinical trials with at least one study location in New Mexico. Data updated daily from ClinicalTrials.gov.

Total Trials
60
Recruiting Now
60
← Back to US Map
Top Conditions in New Mexico
Malignant Solid Neoplasm (4)Melanoma (3)Acute Myeloid Leukemia (3)Lung Non-Small Cell Carcinoma (2)Breast Cancer (2)Sarcoma (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Lymphoblastic Leukemia (2)Atrial Fibrillation (2)Breast Carcinoma (1)Colorectal Carcinoma (1)Non-Hodgkin Lymphoma (1)
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07216482 Phase 3
Recruiting
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-03...
Condition
Hyperlipidemia
Enrollment
975 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04811560 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Condition
Acute Leukemias
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
View Trial →
NCT06667076 Phase 2
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combina...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
480 pts
Location
United States, Belgium, Finland
Sponsor
Janssen Research & Development
View Trial →
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05773274 Phase 2
Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patie...
Condition
Metastatic Digestive System Neuroendocrine Tumor G1
Enrollment
100 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06807424 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Bio...
Condition
Arthritis, Psoriatic
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT06972446 Phase 2
Recruiting
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Ar...
Condition
Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, Canada, Czechia
Sponsor
AbbVie
View Trial →
Page 3 of 3 — 60 trials total
← Prev